Quantitative coronary angiography versus intravascular ultrasound guidance for drug-eluting stent implantation (GUIDE-DES): study protocol for a randomised controlled non-inferiority trial

被引:10
|
作者
Lee, Pil Hyung [1 ]
Hong, Soon Jun [2 ]
Kim, Hyun-Sook [3 ]
Yoon, Young Won [4 ]
Lee, Jong-Young [5 ]
Oh, Seung-Jin [6 ]
Kang, Soo-Jin [1 ]
Kim, Young-Hak [1 ]
Park, Seong-Wook [1 ]
Lee, Seung-Whan [1 ]
Lee, Cheol Whan [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea
[2] Korea Univ, Cardiovasc Ctr, Dept Cardiol, Anam Hosp, Seoul, South Korea
[3] Hallym Univ, Dept Cardiol, Sacred Heart Hosp, Anyang, South Korea
[4] Yonsei Univ, Gangnam Severance Hosp, Div Cardiol, Coll Med, Seoul, South Korea
[5] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Cardiol,Sch Med, Seoul, South Korea
[6] Natl Hlth Insurance Serv Ilsan Hosp, Dept Cardiol, Gyeonggi Do, South Korea
来源
BMJ OPEN | 2022年 / 12卷 / 01期
关键词
CARDIOVASCULAR ANGIOGRAPHY; MYOCARDIAL-INFARCTION; IVUS; OUTCOMES; INTERVENTION; METAANALYSIS; PREDICTORS; LESIONS; REVASCULARIZATION; DEFINITION;
D O I
10.1136/bmjopen-2021-052215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Angiography remains the gold standard for guiding percutaneous coronary intervention (PCI). However, it is prone to suboptimal stent results due to the visual estimation of coronary measurements. Although the benefit of intravascular ultrasound (IVUS)-guided PCI is becoming increasingly recognised, IVUS is not affordable for many catheterisation laboratories. Thus, a more practical and standardised angiography-based approach is necessary to support stent implantation. Methods and analysis The Quantitative Coronary Angiography versus Intravascular Ultrasound Guidance for Drug-Eluting Stent Implantation trial is a randomised, investigator-initiated, multicentre, open-label, non-inferiority trial comparing the quantitative coronary angiography (QCA)-guided PCI strategy with IVUS-guided PCI in all-comer patients with significant coronary artery disease. A novel, standardised, QCA-based PCI protocol for the QCA-guided group will be provided to all participating operators, while the PCI optimisation criteria will be predefined for both strategies. A total of 1528 patients will be randomised to either group at a 1:1 ratio. The primary endpoint is the 12-month cumulative incidence of target-lesion failure defined as a composite of cardiac death, target-vessel myocardial infarction or ischaemia-driven target-lesion revascularisation. Clinical follow-up assessments are scheduled at 1, 6 and 12 months for all patients enrolled in the study. Ethics and dissemination Ethics approval for this study was granted by the Institutional Review Board of Asan Medical Center (no. 2017-0060). Informed consent will be obtained from every participant. The study findings will be published in peer-reviewed journal articles and disseminated through public forums and academic conference presentations. Cost-effectiveness and secondary imaging analyses will be shared in secondary papers.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] The long-term clinical outcomes of intravascular ultrasound-guided versus angiography-guided coronary drug eluting stent implantation in long de novo coronary lesions: A systematic review and meta-analysis
    Wang, Shen
    Liang, Changzai
    Wang, Yue
    Sun, Shuaifeng
    Wang, Yue
    Suo, Min
    Ye, Maomao
    Li, Xinjian
    Liu, Xinyan
    Zhang, Meng
    Wu, Xiaofan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [42] Comparison of the safety and efficacy of two types of drug-eluting balloons (RESTORE DEB and SeQuent® Please) in the treatment of coronary in-stent restenosis: study protocol for a randomized controlled trial (RESTORE ISR China)
    Gao, Lei
    Qin, Qin
    Chen, Shao-Liang
    Chen, Hui
    Wang, Le-Feng
    Jin, Ze-Ning
    Li, Hui
    Zhang, Jun
    Wang, Jian-An
    Zheng, Yang
    Fu, Guo-Sheng
    Chen, Yun-Dai
    JOURNAL OF GERIATRIC CARDIOLOGY, 2018, 15 (02) : 117 - 122
  • [43] Long-Term Clinical Outcomes of Fractional Flow Reserve-Guided Versus Routine Drug-Eluting Stent Implantation in Patients With Intermediate Coronary Stenosis Five-Year Clinical Outcomes of DEFER-DES Trial
    Park, Sang Hyun
    Jeon, Ki-Hyun
    Lee, Joo Myung
    Nam, Chang-Wook
    Doh, Joon-Hyung
    Lee, Bong-Ki
    Rha, Seung-Woon
    Yoo, Ki-dong
    Jung, Kyung Tae
    Cho, Young-Seok
    Lee, Hae-Young
    Youn, Tae-Jin
    Chung, Woo-Young
    Koo, Bon-Kwon
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (12)
  • [44] Safety and efficacy of drug-eluting stents versus heparin-bonded stents in treatment of femoropopliteal peripheral artery disease: study protocol for a multicentre, prospective randomised controlled trial in China (ELITE trial)
    Qi, Yuhan
    Zhang, Huawei
    Zhao, Jichun
    Yuan, Ding
    Wang, Jiarong
    Ge, Jinting
    Huang, Bin
    Weng, Chengxin
    Wang, Tiehao
    BMJ OPEN, 2024, 14 (08):
  • [45] Five-year results of the complete versus culprit vessel percutaneous coronary intervention in multivessel disease using drug-eluting stentsII (CORRECTII) study: aprospective, randomised controlled trial
    Fagel, N. D.
    van Nooijen, F. C.
    Maarse, M.
    Slagboom, T.
    Herrman, J. P.
    van der Schaaf, R. J.
    Amoroso, G.
    Patterson, M. S.
    Laarman, G. J.
    Suttorp, M. J.
    Vink, M. A.
    NETHERLANDS HEART JOURNAL, 2019, 27 (06) : 310 - 320
  • [46] Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study
    Byrne, Robert A.
    Schulz, Stefanie
    Mehilli, Julinda
    Ijima, Raisuke
    Massberg, Steffen
    Neumann, Franz-Josef
    ten Berg, Jurrien M.
    Schoemig, Albert
    Kastrati, Adnan
    AMERICAN HEART JOURNAL, 2009, 157 (04) : 620 - 624
  • [47] Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)
    Bitterman, Roni
    Koppel, Fidi
    Mussini, Cristina
    Geffen, Yuval
    Chowers, Michal
    Rahav, Galia
    Nesher, Lior
    Ben-Ami, Ronen
    Turjeman, Adi
    Samuel, Maayan Huberman
    Cheng, Matthew P.
    Lee, Todd C.
    Leibovici, Leonard
    Yahav, Dafna
    Paul, Mical
    BMJ OPEN, 2021, 11 (02):
  • [48] Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE)
    Schmitz, Thomas
    Alberti, Corinne
    Ursino, Moreno
    Baud, Olivier
    Aupiais, Camille
    BMC PREGNANCY AND CHILDBIRTH, 2019, 19 (1)
  • [49] Non-inferiority and cost-effectiveness trial of isolated biceps tenotomy versus tenotomy with rotator cuff repair in patients with stage 2-3 Goutallier fatty degenerative cuff lesions (TenCuRe study): protocol of a multicentre randomised controlled trial
    Hollman, Freek
    Wolterbeek, Nienke
    Auw Yang, Gie
    BMJ OPEN, 2020, 10 (01):
  • [50] Non-inferiority of sodium zirconium cyclosilicate versus potassium-restricted diet in achieving normokalaemia in patients with type 2 diabetes mellitus: protocol for a multicentre, open-label, randomised controlled, two-arm clinical trial (SILVERSTAR study)
    Hironaka, Junya
    Okada, Hiroshi
    Osaka, Takafumi
    Hashimoto, Yoshitaka
    Kobayashi, Genki
    Tanaka, Muhei
    Kogure, Akinori
    Mitsuhashi, Kazuteru
    Yoshimura, Takashi
    Kitagawa, Noriyuki
    Yano, Miho
    Kitamura, Akane
    Kishi, Akio
    Tsutsumi, Takeshi
    Yamazaki, Masahiro
    Ishii, Michiyo
    Mogami, Shinichi
    Nakamura, Naoto
    Fukuda, Takuya
    Tanaka, Toru
    Bamba, Ryo
    Sato, Eiko
    Hamaguchi, Masahide
    Fukui, Michiaki
    BMJ OPEN, 2025, 15 (03):